Professor Linda Partridge was recently interviewed by Time Out London and features in today's issue ('Rad Scientists', Time Out, 20/09/2016). You can read the article via our Facebook site at https://www.facebook.com/UCLInstituteofHealthyAgeing/
Published: Sep 20, 2016 11:43:25 AM
Congratulations to Dr Teresa Niccoli whose paper "Increased Glucose Transport into Neurons Rescues Ab Toxicity in Drosophila" has just been published in Current Biology by Cell Press. More...
Published: Aug 17, 2016 3:05:35 PM
The Institute of Healthy Ageing is currently seeking a post-doctoral research associate to work on the following ARUK-funded project.
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating, mid-life, neurodegenerative disorders for which no cure is currently available. Large expansions of a hexanucleotide GGGGCC-repeat in the first intron of the C9orf72 gene is the most common genetic cause of both ALS and FTD. We recently developed novel Drosophila models of C9orf72 repeat-induced neurodegeneration (Mizielinska et al Science 2014, 345:1192-1194).
This 3-year post-doctoral position will build on this work by investigating disease mechanisms in a range of C9orf72 fly lines using several approaches including genome-wide transcriptomic and translational analyses in both flies and iPSC-neurons. You will work as part of a collaborative team of investigators in the excellent and supportive scientific research community of UCL.
The post is funded for 3 years in the first instance by Alzheimer’s Research UK and is available from October 2016.
For full information and to apply please visit the UCL website at https://goo.gl/E5vk8j
Published: Aug 11, 2016 2:27:25 PM
The Institute of Healthy Ageing (Director: Prof Dame Linda Partridge,
DBE, FRS, FRSE, FMedSci) is an interdisciplinary centre of excellence
for research on the biology of ageing and ageing-related diseases. The
biological process of ageing contributes to increased risk of a wide
range of diseases, from neurodegenerative diseases (e.g. Alzheimer's and
Parkinson's disease) and cancer to cardiovascular disease (causing
heart attack and stroke) and age-related macular degeneration (causing
blindness in the elderly).
Our primary purpose is to bring together researchers working on the basic biology of ageing (biogerontology) with those working to understand the causes of ageing-related disease. By merging the two, we aim to develop a new translational biogerontology using the ageing process as a point of intervention to protect against the diseases of old age. Our goal is to improve the health and quality of life for older people.
The work of the Institute of Healthy Ageing is pursuing these ends by:
- Conducting world class research on the biology of ageing and ageing-related disease
- Increasing capacity in research on the biology of ageing by training new researchers and nurturing the work of younger principal investigators
- Teaching about the biology of ageing at undergraduate and postgraduate levels
problem of ageing is not just an issue of biology, but also of social
science, economics and the built environment. A secondary aim of the
Institute is to nurture broader collaborations across UCL between
researchers working on different aspects of ageing.
We aim, through our combined activities, to transform healthcare technology and the social conditions of the elderly to create a future society in which the lives of older people are healthy, meaningful and happy.
Our facilities are shared with the associated Bähler Lab, headed by Professor Jürg Bähler.
Page last modified on 05 nov 15 14:26